Joint Ventures

News Joint Ventures

• DSM and Sinochem Group establish global anti-infectives joint venture

  Royal DSM announced that it has established the 50/50 global joint venture for its business group DSM Anti-Infectives with Sinochem Group. All applicable regulatory approvals and customary clearances from competition authorities have been received. The agreement to form the joint venture was announc more

• Isogenica, Biolauncher and Cresset Biomolecular Discovery forge alliance to bring powerful target-to-drugs platform to market

  Isogenica Ltd announced a collaborative joint venture with Biolauncher Ltd  and Cresset Biomolecular Discovery Ltd to develop an innovative end-to-end therapeutic discovery platform. Under the terms of the collaboration the parties will integrate their expertise in peptide library design, evolutiona more

• Bayer and Zydus Cadila sign Joint Venture Agreement to strengthen pharmaceutical business in India

  Bayer HealthCare and the Indian company Zydus Cadila signed an agreement in Mumbai, India, to form the Joint Venture Company Bayer Zydus Pharma. With this newly established marketing and sales enterprise, Bayer aims to enhance its presence in the fast growing pharmaceutical market in India. Each more

White papers Joint Ventures

• Half a Century of Chromatography with Agilent and Predecessors
  

  Twsett originated the chromatography with his work about the separation of chlorophyll in 1903. For some time it was relatively quite around this new technology. Exceptions were the workings of Kuhn and Lederer (1931) as well as of Hesse (1936 and 1942). A break through succeeded to E. Cremer during the 40ies, but hardly considered caused by the war events, what however in the years 1950/51 by the conception of the gas chromatography suddenly changed and involved a rapid development more

Publications Joint Ventures

• An agenda for UK clinical pharmacology
How should training of graduates in clinical pharmacology and therapeutics be delivered and assessed?

  Abstract The UK postgraduate curriculum in clinical pharmacology and therapeutics (CPT) incorporates the common competencies required of all physicians and shows how trainees from other specialties, including primary care, can train in CPT. Various models of training and assessment are possibl more

Market studies Joint Ventures

• Czech Republic Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: We retain our negative outlook for the pharmaceutical market in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear (y-o-y) decrease calculated for 2011. While the increase in the value-added tax (VAT) will negate th more

• China Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: 2012 is a very important year for the country as the government look to carry on their achievements following the healthcare reform in 2009. We highlight that the expansion of the National Essential Drug List (NEDL) slated to happen this year will bring strong opportunities for pharmaceuti more

• Uzbekistan Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Uzbekistan’s pharmaceutical market remains one of the fastest growing in the Central and Eastern Europe (CEE) region and its population and currently low levels of per capita pharmaceutical spending gives it the greatest long-term growth potential of any Central Asian market. BMI forecasts more

Websites Joint Ventures